应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02158 医渡科技
交易中 11-25 15:13:03
4.860
+0.390
+8.72%
最高
5.080
最低
4.600
成交量
5,161万
今开
4.780
昨收
4.470
日振幅
10.74%
总市值
51.60亿
流通市值
51.60亿
总股本
10.62亿
成交额
2.49亿
换手率
4.86%
流通股本
10.62亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
异动解读 | 医渡科技(02158.HK)盘中大涨7.16%,公司大模型"YiduCore"赋能全场景医疗解决方案落地
异动解读 · 09:30
异动解读 | 医渡科技(02158.HK)盘中大涨7.16%,公司大模型"YiduCore"赋能全场景医疗解决方案落地
医渡科技(02158)2025财年中期经调整EBITDA持续盈利,获花旗、光大证券等多家机构“买入”评级
智通财经 · 11:43
医渡科技(02158)2025财年中期经调整EBITDA持续盈利,获花旗、光大证券等多家机构“买入”评级
【港股通】医渡科技(02158)涨10.07% AI辅助诊断服务落地
金吾财讯 · 11:09
【港股通】医渡科技(02158)涨10.07% AI辅助诊断服务落地
港股异动 | 医渡科技(02158)涨超10% AI辅助诊断被列入医保局立项指南 公司大模型落地提速
智通财经 · 09:33
港股异动 | 医渡科技(02158)涨超10% AI辅助诊断被列入医保局立项指南 公司大模型落地提速
医渡科技盘中异动 早盘股价大涨8.05%报4.830港元
市场透视 · 09:30
医渡科技盘中异动 早盘股价大涨8.05%报4.830港元
港股概念追踪|AI辅助诊断服务也能收费了 AI工具在医疗领域的应用前景广阔(附概念股)
智通财经 · 09:28
港股概念追踪|AI辅助诊断服务也能收费了 AI工具在医疗领域的应用前景广阔(附概念股)
【医渡科技(2158.HK)】经调整EBITDA持续盈利,YiduCore赋能全场景解决方案落地——2025财年中期业绩点评报告
光大证券研究 · 07:04
【医渡科技(2158.HK)】经调整EBITDA持续盈利,YiduCore赋能全场景解决方案落地——2025财年中期业绩点评报告
医渡科技:坚定布局医疗大模型 亏损幅度收窄
中金公司 · 00:00
医渡科技:坚定布局医疗大模型 亏损幅度收窄
医渡科技(02158)2025财年中期经调整EBITDA持续盈利 4月以来已回购超2200万港元
智通财经 · 11-22
医渡科技(02158)2025财年中期经调整EBITDA持续盈利 4月以来已回购超2200万港元
【港股通】医渡科技盘初跌11.56% 中期收入同比减少7.6%至3.29亿元人民币
金吾资讯 · 11-22
【港股通】医渡科技盘初跌11.56% 中期收入同比减少7.6%至3.29亿元人民币
医渡科技盘中异动 快速下跌7.16%
市场透视 · 11-22
医渡科技盘中异动 快速下跌7.16%
【湾区早参】香港10月综合CPI同比增长1.4%;深圳“两新”撬动汽车、家电等产品销售额超530亿元
金吾财讯 · 11-22
【湾区早参】香港10月综合CPI同比增长1.4%;深圳“两新”撬动汽车、家电等产品销售额超530亿元
【港股通】医渡科技半年亏损同比收窄42.66%至4344.6万元人民币 不派中期息
金吾资讯 · 11-21
【港股通】医渡科技半年亏损同比收窄42.66%至4344.6万元人民币 不派中期息
医渡科技中期业绩:总收入3.29亿元,同比降7.6%
财中社 · 11-21
医渡科技中期业绩:总收入3.29亿元,同比降7.6%
医渡科技(02158)2025财年中期经调整EBITDA持续转正 大模型落地提速
智通财经 · 11-21
医渡科技(02158)2025财年中期经调整EBITDA持续转正 大模型落地提速
一图看懂 | 医渡科技(02158)FY25中期业绩:经调整EBITDA持续转正 盈利水平接近去年全年
智通财经网 · 11-21
一图看懂 | 医渡科技(02158)FY25中期业绩:经调整EBITDA持续转正 盈利水平接近去年全年
医渡科技(02158)发布中期业绩 毛利1.17亿元 继续保持医院临床研究第一品牌的地位
智通财经 · 11-21
医渡科技(02158)发布中期业绩 毛利1.17亿元 继续保持医院临床研究第一品牌的地位
《业绩》医渡科技(02158.HK)半年亏损收窄至4,344.6万元人民币
阿斯达克财经 · 11-21
《业绩》医渡科技(02158.HK)半年亏损收窄至4,344.6万元人民币
医渡科技上榜11月21日主力资金加仓幅度前10个股(附名单)
市场透视 · 11-21
医渡科技上榜11月21日主力资金加仓幅度前10个股(附名单)
医渡科技(02158)下跌10.18%,报5.38元/股
金融界 · 11-21
医渡科技(02158)下跌10.18%,报5.38元/股
加载更多
公司概况
公司名称:
医渡科技
所属市场:
SEHK
上市日期:
--
主营业务:
医渡科技有限公司是一家主要提供医疗大数据解决方案的中国投资控股公司。该公司通过三个分部运营。大数据平台和解决方案分部主要由大数据平台产品和为客户提供的其他解决方案组成。生命科学解决方案分部负责向制药、生物技术和医疗设备等公司提供分析驱动型临床开发、基于真实世界证据 (RWE)的研究以及数字化营销解决方案。健康管理平台和服务分部主要运营研究驱动型个人健康管理平台,以及向保险公司和代理机构提供保险科技和疾病管理解决方案。该公司主要数据智能基础设施为YiduCore。
发行价格:
--
{"stockData":{"symbol":"02158","market":"HK","secType":"STK","nameCN":"医渡科技","latestPrice":4.86,"timestamp":1732518780283,"preClose":4.47,"halted":0,"volume":51607144,"delay":0,"floatShares":1061662666,"shares":1061662666,"eps":-0.19899446,"marketStatus":"交易中","marketStatusCode":2,"change":0.39,"latestTime":"11-25 15:13:03","open":4.78,"high":5.08,"low":4.6,"amount":249290389,"amplitude":0.107383,"askPrice":4.86,"askSize":53600,"bidPrice":4.85,"bidSize":6100,"shortable":3,"etf":0,"ttmEps":-0.1657059747430341,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732522200000},"adr":0,"listingDate":1610640000000,"adjPreClose":4.47,"openAndCloseTimeList":[[1732498200000,1732507200000],[1732510800000,1732521600000]],"volumeRatio":1.582954,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02158","defaultTab":"news","newsList":[{"id":"1119293084","title":"异动解读 | 医渡科技(02158.HK)盘中大涨7.16%,公司大模型\"YiduCore\"赋能全场景医疗解决方案落地","url":"https://stock-news.laohu8.com/highlight/detail?id=1119293084","media":"异动解读","labels":["movement"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119293084?lang=zh_cn&edition=full","pubTime":"2024-11-25 09:30","pubTimestamp":1732498253,"startTime":"0","endTime":"0","summary":"医渡科技今日盘中大涨7.16%,引起市场广泛关注。公司2025财年中期业绩报告显示,公司大数据平台与解决方案板块收入较去年同期上升4.5%,主要得益于公司自研大模型\"YiduCore\"在全场景医疗解决方案领域的应用。YiduCore已经获得授权处理和分析超过55亿份医疗记录,覆盖2,800多家医院。该板块的前10大客户收入留存率高达117.45%,且客单价同比大幅上升。公司已成为全球16家头部跨国药企的供应商,中长期市占率有望继续提升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 医渡科技(02158.HK)盘中大涨7.16%,公司大模型\"YiduCore\"赋能全场景医疗解决方案落地","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02158"],"gpt_icon":0},{"id":"2486725355","title":"医渡科技(02158)2025财年中期经调整EBITDA持续盈利,获花旗、光大证券等多家机构“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2486725355","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486725355?lang=zh_cn&edition=full","pubTime":"2024-11-25 11:43","pubTimestamp":1732506213,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,近日,医渡科技2025财年中期业绩出炉,公司现有业务管理口径经调整EBITDA自上一财年扭亏为盈后,持续实现盈利超过人民币2700万元,中期盈利水平已与2024财年全年基本持平。花旗指出,医渡科技在2025财年上半年亏损持续收窄,公司期间亏损收窄至人民币5636万元,同比大幅减亏29.2%。因此维持对医渡科技的“买入”评级,目标价为8港元。截至发稿前,医渡科技股价上涨8.28%,报4.85港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215217.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158","601788"],"gpt_icon":0},{"id":"2486155723","title":"【港股通】医渡科技(02158)涨10.07% AI辅助诊断服务落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2486155723","media":"金吾财讯","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486155723?lang=zh_cn&edition=full","pubTime":"2024-11-25 11:09","pubTimestamp":1732504170,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医渡科技 股价走高,截至发稿,涨10.07%,报4.92港元,成交额1.75亿港元。消息面上,国家医保局23日下午召开新闻发布会,解读17批价格立项。国内咨询机构科方得智库研究负责人张新原认为:“AI可以辅助医生进行更精准的诊断和治疗,如通过图像识别技术辅助诊断疾病,通过自然语言处理和智能回答系统辅助患者和医生进行沟通等。随着AI技术的不断应用和普及,产业链上市公司将迎来更多的发展机遇。”","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NTRmYzVmNDdmYzg0MjRhYWE5NzljZDI3ZDUxMDYzNjE2NzY4MDQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NTRmYzVmNDdmYzg0MjRhYWE5NzljZDI3ZDUxMDYzNjE2NzY4MDQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1948323","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","BK1518","YANG","HSCEI","02158","BK1189"],"gpt_icon":0},{"id":"2486413537","title":"港股异动 | 医渡科技(02158)涨超10% AI辅助诊断被列入医保局立项指南 公司大模型落地提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2486413537","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486413537?lang=zh_cn&edition=full","pubTime":"2024-11-25 09:33","pubTimestamp":1732498410,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,医渡科技涨超10%,截至发稿,涨10.29%,报4.93港元,成交额4209.65万港元。消息面上,国家医保局23日下午召开新闻发布会,解读17批价格立项。医渡科技近日发布2025财年中期业绩,期内实现总收入为人民币3.29亿元。期间亏损缩减至人民币5636万元,同比减亏29.2%,现金流持续优化提升。自5月MedBench评测名列第一后,在9月28日揭晓的由国家卫健委组织的大模型分导诊能力评测中,医渡科技大模型再次排名第一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","BK1189","02158"],"gpt_icon":0},{"id":"2486741892","title":"医渡科技盘中异动 早盘股价大涨8.05%报4.830港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486741892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486741892?lang=zh_cn&edition=full","pubTime":"2024-11-25 09:30","pubTimestamp":1732498208,"startTime":"0","endTime":"0","summary":"2024年11月25日早盘09时30分,医渡科技股票出现异动,股价大幅拉升8.05%。截至发稿,该股报4.830港元/股,成交量192.99万股,换手率0.18%,振幅2.24%。资金方面,该股资金流入146.04万港元,流出109.012万港元。医渡科技股票所在的医疗及医学美容服务行业中,整体涨幅为0.03%。报告期内,公司持续坚持“聚焦”战略,实现总收入为人民币3.29亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112509300898e44472&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112509300898e44472&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1518","BK1189","02158"],"gpt_icon":0},{"id":"2486416517","title":"港股概念追踪|AI辅助诊断服务也能收费了 AI工具在医疗领域的应用前景广阔(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2486416517","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486416517?lang=zh_cn&edition=full","pubTime":"2024-11-25 09:28","pubTimestamp":1732498126,"startTime":"0","endTime":"0","summary":"人工智能辅助诊断首次被列入国家医保局立项指南。为了支持相对成熟的人工智能辅助技术进入临床应用,同时防止额外增加患者负担,国家医保局分析人工智能潜在的应用场景,在放射检查、超声检查、康复类项目中设立“人工智能辅助”扩展项。随着技术的不断进步,AI工具在医疗领域的应用前景广阔,且AI技术在医疗界的应用不仅限于辅助诊断,在新药发现、健康管理、手术辅助、治疗规划、患者服务等方面,AI均可助人类医生一臂之力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","HSCEI","BK1591","BK1610","BK1515","YANG","BK1247","BK1584","BK1502","00241","BK1189","BK1589","BK1571","BK1142","BK1501","02158","HSTECH","159891"],"gpt_icon":1},{"id":"2486571746","title":"【医渡科技(2158.HK)】经调整EBITDA持续盈利,YiduCore赋能全场景解决方案落地——2025财年中期业绩点评报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2486571746","media":"光大证券研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486571746?lang=zh_cn&edition=full","pubTime":"2024-11-25 07:04","pubTimestamp":1732489473,"startTime":"0","endTime":"0","summary":"大数据平台解决方案板块收入同比上升,AI医疗智能大脑YiduCore赋能全场景解决方案落地FY1H25 BDPS板块收入1.34亿元人民币,同比上升4.5%;毛利率同比下降7.8pct至37.4%,由于产品组合变化,其中纯服务部分毛利率同比上升1.5pct至47.7%。期内YiduCore经授权处理及分析超过11亿名患者的55亿份医疗记录,并覆盖超过2,800家医院。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125071140abdc34f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125071140abdc34f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1518","BK1189","02158"],"gpt_icon":0},{"id":"2486747431","title":"医渡科技:坚定布局医疗大模型 亏损幅度收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2486747431","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486747431?lang=zh_cn&edition=full","pubTime":"2024-11-25 00:00","pubTimestamp":1732464000,"startTime":"0","endTime":"0","summary":"2025 财年上半年,受外部市场环境及产品组合变化的影响,医渡科技收入同比下滑7.6%至3.3 亿元。坚定投入人工智能,打造AI 中台产品。2025 财年上半年,医渡科技继续优化并训练面向医疗垂直领域的大语言模型,聚焦70B 参数的模型训练,建立数据中台+AI 中台模式,在诊断和科研等场景落地AI 功能。管理层在业绩会公开表示,当前公司研发费用中约50%投入到了AI 大模型领域。亏损幅度收窄,现金流情况改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125102130abdc9940&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125102130abdc9940&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1518","02158","BK1189"],"gpt_icon":0},{"id":"2485037414","title":"医渡科技(02158)2025财年中期经调整EBITDA持续盈利 4月以来已回购超2200万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485037414","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485037414?lang=zh_cn&edition=full","pubTime":"2024-11-22 10:52","pubTimestamp":1732243966,"startTime":"0","endTime":"0","summary":"报告期内,公司持续坚持“聚焦”战略,实现总收入为人民币3.29亿元。公司现有业务管理口径经调整EBITDA自上一财年扭亏为盈后持续实现盈利超过人民币2700万元,中期盈利水平已与2024财年全年基本持平。得益于内部运营效率的提升以及各业务板块间的协同效应增强,公司期内亏损收窄至人民币5636万元,同比大幅减亏29.2%,现金流持续优化提升。据悉,自今年4月以来,医渡科技已从二级市场回购超2200万港元的股票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","BK1189","02158"],"gpt_icon":0},{"id":"2485547227","title":"【港股通】医渡科技盘初跌11.56% 中期收入同比减少7.6%至3.29亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2485547227","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485547227?lang=zh_cn&edition=full","pubTime":"2024-11-22 09:36","pubTimestamp":1732239415,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医渡科技 盘初走低,截至发稿,跌11.56%,报4.82港元,成交额1752.86万港元。董事会不建议分派截至2024年9月30日止六个月的中期股息。期内,收入3.29亿元,同比减少7.6%。整体毛利率为35.6%,同比减少2.6个百分点;研发开支同比减少9.6%至9370万元,主要归因于从事研发职能的雇员之雇员福利及开支由7010万元减少至4930万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122093708a24c9a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122093708a24c9a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","BK1518","HSTECH","BK1189","02158"],"gpt_icon":0},{"id":"2485474994","title":"医渡科技盘中异动 快速下跌7.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485474994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485474994?lang=zh_cn&edition=full","pubTime":"2024-11-22 09:30","pubTimestamp":1732239003,"startTime":"0","endTime":"0","summary":"2024年11月22日早盘09时30分,医渡科技股票出现异动,股价急速跳水7.16%。医渡科技股票所在的医疗及医学美容服务行业中,整体跌幅为0.02%。其相关个股中,环球医疗、完美医疗、瑞尔集团涨幅较大,振幅较大的相关个股有医渡科技、海吉亚医疗、康圣环球,振幅分别为0.73%、0.11%、0.00%。消息层面,截至09时30分,《医渡科技2025财年中期经调整EBITDA持续转正 大模型落地提速》资讯为影响医渡科技的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122093004abd605ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122093004abd605ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1518","BK1189","02158"],"gpt_icon":0},{"id":"2485815479","title":"【湾区早参】香港10月综合CPI同比增长1.4%;深圳“两新”撬动汽车、家电等产品销售额超530亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485815479","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485815479?lang=zh_cn&edition=full","pubTime":"2024-11-22 08:33","pubTimestamp":1732235595,"startTime":"0","endTime":"0","summary":"“叠加今年5月启动的以旧换新等相关补贴活动,共撬动汽车、家电等产品销售额超530亿元。”归属于普通股股东的每股净收益1.03元。期内集团净收入总额623.32亿元,同比增长8.27%。月内收入乘客千米数按年上升19.1%。国泰航空于2024年10月份运载了14.23万公吨货物,较去年同月增加14.3%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/ZjAzYmQ0ZTAxMjgwMmU1OWFmMjcwNDc3NDA4NDI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZjAzYmQ0ZTAxMjgwMmU1OWFmMjcwNDc3NDA4NDI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1948200","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00035","LU1008478684.HKD","BK4558","SG9999002828.SGD","01919","HK0000306685.HKD","LU0039217434.USD","LU0348825331.USD","BK4581","BK1095","LU0287142896.SGD","LU1048588211.SGD","LU1515016050.SGD","BK1103","89888","02423","BK1240","LU0052756011.USD","LU0197773673.USD","LU0163747925.USD","LU1823568750.SGD","00590","BK4122","02158","IE00BFMHRM44.USD","LU0640798160.USD","BK4503","09888","BK4554","LU0326950275.SGD","LU0821914370.USD","BK1505","HK0000320264.USD","BK1587","BK1535","09988","LU0315179316.USD","BK4220","LU0320764599.SGD","LU0880133367.SGD","BK1502","BIDU","LU1115378108.SGD","00293","LU0128525689.USD","BK1097","BK4504","BK4505","LU0359201612.USD"],"gpt_icon":1},{"id":"2485452053","title":"【港股通】医渡科技半年亏损同比收窄42.66%至4344.6万元人民币 不派中期息","url":"https://stock-news.laohu8.com/highlight/detail?id=2485452053","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485452053?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:30","pubTimestamp":1732181443,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医渡科技 公告,截至2024年9月30日止六个月,公司拥有人应占亏损4344.6万元,同比收窄42.66%;期内亏损5640万元,同比减少29.15%;每股基本亏损0.04元。董事会不建议分派截至2024年9月30日止六个月的中期股息。期内,收入3.29亿元,同比减少7.6%。整体毛利率为35.6%,同比减少2.6个百分点。期内,研发开支同比减少9.6%至9370万元,主要归因于从事研发职能的雇员之雇员福利及开支由7010万元减少至4930万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121173126abd453be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121173126abd453be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1518","HSTECH","02158","BK1189","HSCEI"],"gpt_icon":0},{"id":"2485452703","title":"医渡科技中期业绩:总收入3.29亿元,同比降7.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485452703","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485452703?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:21","pubTimestamp":1732180914,"startTime":"0","endTime":"0","summary":"财中社11月21日电医渡科技(02158)发布中期业绩,截至2024年9月30日的六个月内,公司总收入为3.29亿元,同比下降7.6%。其中,大数据平台和解决方案的收入为1.34亿元,增长4.5%;生命科学解决方案的收入为1.45亿元,下降15%;健康管理平台和解决方案的收入为5116万元,下降12.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411213246826628.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1189","BK1518","02158"],"gpt_icon":0},{"id":"2485452321","title":"医渡科技(02158)2025财年中期经调整EBITDA持续转正 大模型落地提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2485452321","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485452321?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:18","pubTimestamp":1732180738,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,11月21日,医渡科技2025财年中期业绩出炉。截至2024年9月30日的六个月内,医渡科技持续坚持“聚焦”战略,实现总收入为人民币3.29亿元。期间亏损缩减至人民币5636万元,同比减亏29.2%。此外据官方消息,公司现有业务管理口径经调整EBITDA自上一财年扭亏为盈后持续实现盈利超人民币2700万元,中期盈利水平已与2024财年全年基本持平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","BK1189","02158"],"gpt_icon":0},{"id":"2485452741","title":"一图看懂 | 医渡科技(02158)FY25中期业绩:经调整EBITDA持续转正 盈利水平接近去年全年","url":"https://stock-news.laohu8.com/highlight/detail?id=2485452741","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485452741?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:15","pubTimestamp":1732180527,"startTime":"0","endTime":"0","summary":"更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02158","BK1518","BK1189"],"gpt_icon":0},{"id":"2485454797","title":"医渡科技(02158)发布中期业绩 毛利1.17亿元 继续保持医院临床研究第一品牌的地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2485454797","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485454797?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:14","pubTimestamp":1732180472,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医渡科技 发布截至2024年9月30日止六个月的中期业绩,该集团期内取得客户合同收入3.29亿元;毛利1.17亿元;研发开支9368.2万元。截至2024年9月30日,集团向105家中国顶级医院以及40个监管机构和政策制定者提供了解决方案,覆盖超过2800家医院。在科研领域,集团与知名机构合作,推动技术迭代,参与了20余个国家级和省部级的医学研究课题,继续保持医院临床研究第一品牌的地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158","BK1518","BK1189"],"gpt_icon":0},{"id":"2485454360","title":"《业绩》医渡科技(02158.HK)半年亏损收窄至4,344.6万元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2485454360","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485454360?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:04","pubTimestamp":1732179840,"startTime":"0","endTime":"0","summary":"医渡科技(02158.HK) 公布截至今年9月底止中期业绩,营业额3.29亿元人民币(下同),按年跌7.6%。亏损收窄至4,344.6万元,上年同期蚀7,576.9万元;每股亏损4分。不派息。(sl/k)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-21 16:25。)过往派息公布日期派息事项派息内容2024/06/27末期业绩无派息2023/11/29中期业绩无派息2023/06/30末期业绩无派息2022/11/25中期业绩无派息AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210415113531961_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210415113531961_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1398549/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02158","BK1518","BK1189"],"gpt_icon":0},{"id":"2485345525","title":"医渡科技上榜11月21日主力资金加仓幅度前10个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485345525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485345525?lang=zh_cn&edition=full","pubTime":"2024-11-21 16:16","pubTimestamp":1732176972,"startTime":"0","endTime":"0","summary":"11月21日, 医渡科技股价跌9.02%,报收5.45元,成交金额2.52亿元,换手率4.35%,振幅13.02%,量比1.42。医渡科技今日主力资金净流入1383万元,上一交易日主力净流入1295万元,今日环比增加6.80%。该股近5个交易日上涨2.83%,主力资金累计净流入2082万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入8019万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121161628abd42825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121161628abd42825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1518","02158","BK1189"],"gpt_icon":0},{"id":"2485832374","title":"医渡科技(02158)下跌10.18%,报5.38元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485832374","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485832374?lang=zh_cn&edition=full","pubTime":"2024-11-21 10:18","pubTimestamp":1732155539,"startTime":"0","endTime":"0","summary":"11月21日,医渡科技(02158)盘中下跌10.18%,截至10:18,报5.38元/股,成交8941.64万元。医渡科技有限公司是一家医疗人工智能技术公司,主要提供数据智能驱动的创新医疗解决方案,通过医疗AI技术打通信息壁垒,助力政府、医院和整个产业界实现医疗智能化。自2014年以来,医渡云利用其自主开发的“医学数据智能平台”,通过深度处理和分析建立疾病领域模型,以推动医学研究、医疗管理、政府决策、新药研发和智能化疾病管理。截至2023年年报,医渡科技营业总收入8.07亿元、净利润-1.95亿元。11月21日,医渡科技披露2024财年中报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/21101845512231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02158","BK1189","BK1518"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1183},{"period":"1month","weight":0.2213},{"period":"3month","weight":0.3969},{"period":"6month","weight":0.1147},{"period":"1year","weight":-0.0609},{"period":"ytd","weight":-0.1166}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0737},{"period":"3month","weight":0.0919},{"period":"6month","weight":0.0334},{"period":"1year","weight":0.0736},{"period":"ytd","weight":0.128}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"医渡科技有限公司是一家主要提供医疗大数据解决方案的中国投资控股公司。该公司通过三个分部运营。大数据平台和解决方案分部主要由大数据平台产品和为客户提供的其他解决方案组成。生命科学解决方案分部负责向制药、生物技术和医疗设备等公司提供分析驱动型临床开发、基于真实世界证据 (RWE)的研究以及数字化营销解决方案。健康管理平台和服务分部主要运营研究驱动型个人健康管理平台,以及向保险公司和代理机构提供保险科技和疾病管理解决方案。该公司主要数据智能基础设施为YiduCore。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.182051},{"month":2,"riseRate":0.5,"avgChangeRate":0.072152},{"month":3,"riseRate":0,"avgChangeRate":-0.145896},{"month":4,"riseRate":0.5,"avgChangeRate":-0.026639},{"month":5,"riseRate":0,"avgChangeRate":-0.077808},{"month":6,"riseRate":0.5,"avgChangeRate":0.082247},{"month":7,"riseRate":0,"avgChangeRate":-0.097171},{"month":8,"riseRate":0.25,"avgChangeRate":-0.119508},{"month":9,"riseRate":0.5,"avgChangeRate":-0.106702},{"month":10,"riseRate":0.25,"avgChangeRate":-0.052414},{"month":11,"riseRate":0.75,"avgChangeRate":0.146236},{"month":12,"riseRate":0.666667,"avgChangeRate":0.063814}],"exchange":"SEHK","name":"医渡科技","nameEN":"YIDU TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医渡科技,02158,医渡科技股票,医渡科技股票老虎,医渡科技股票老虎国际,医渡科技行情,医渡科技股票行情,医渡科技股价,医渡科技股市,医渡科技股票价格,医渡科技股票交易,医渡科技股票购买,医渡科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}